- Active Ingredients
Product Documentation
-
View RMM (Fingolimod Patient Reminder Card)
Last updated on this site: 07 Jun 2023
Administration update only - no change to content
View RMM (Fingolimod Patient, Parent, Caregiver Guide)Last updated on this site: 07 Jun 2023
Administration update only - no change to content
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaintFingolimod Accord 0.5 mg hard Capsules
- PL Number:
- EU/1/20/1450/001-006
- MA Holder:
- Accord Healthcare S.L.U
- Product Classification:
-
POM
- Product Status:
- Active
Product Documentation
-
View Patient Information Leaflet (PIL - Fingolimod Accord 0.5 mg hard Capsules)
Last updated on this site: 09 Aug 2024
To register the deletion of Pharmadox Healthcare Limited, KW20A Kordin Industrial Park, Paola PLA 3000, Malta as a manufacturing site responsible for batch release for the finished product.
View Summary of Product Characteristics (SmPC - Fingolimod Accord 0.5 mg hard Capsules)Last updated on this site: 04 Feb 2025
Renewal Approval
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.
Report a side effect or a product complaint
For any further assistance, please get in touch.